These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 20141676)

  • 21. [Clinics in prostate cancer].
    Sugimura Y
    Rinsho Byori; 2004 Jul; 52(7):604-10. PubMed ID: 15344560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
    Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F;
    Eur Urol; 2011 Jan; 59(1):61-71. PubMed ID: 21056534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combating prostate cancer.
    Garnick MB; Fair WR
    Sci Am; 1998 Dec; 279(6):74-83. PubMed ID: 9828467
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surgical and medical treatment for localized prostate cancer].
    Kawai K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1002-5. PubMed ID: 17637535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of immediate androgen deprivation adjuvant therapy in patients with lymph node positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy].
    Miyamae K; Kitani K; Miyamoto K; Hamada S; Kawano T; Maehara A; Otsuka Y; Otsuka T; Hamada Y
    Nihon Hinyokika Gakkai Zasshi; 2009 Jul; 100(5):570-5. PubMed ID: 19663244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential therapy of prostate cancer].
    Jäger T; Rübben H; Börgermann C
    Internist (Berl); 2007 Dec; 48(12):1382-7. PubMed ID: 17965846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facing up to prostate cancer.
    Ficorelli CT; Weeks B
    Nursing; 2006 May; 36(5):66-8. PubMed ID: 16670611
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition).
    Kamidono S; Ohshima S; Hirao Y; Suzuki K; Arai Y; Fujimoto H; Egawa S; Akaza H; Hara I; Hinotsu S; Kakehi Y; Hasegawa T;
    Int J Urol; 2008 Jan; 15(1):1-18. PubMed ID: 18184166
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment options in lymph node-positive prostate cancer.
    Swanson GP; Thompson IM; Basler J
    Cancer; 2006 Jun; 106(12):2531-9. PubMed ID: 16700035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of active surveillance in the management of prostate cancer.
    Fung-Kee-Fung SD; Porten SP; Meng MV; Kuettel M
    J Natl Compr Canc Netw; 2013 Feb; 11(2):183-7. PubMed ID: 23411385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of patients with prostate cancer: the nurse's role.
    Turner B
    Nurs Stand; 2007 Jun 6-12; 21(39):48-56; quiz 58. PubMed ID: 17569378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncology today: new horizons. Prostate cancer.
    Greifzu SP
    RN; 2000 Jun; 63(6):26-31; quiz 32. PubMed ID: 10897747
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostate carcinoma practice patterns: what do they tell us about the diagnosis, treatment, and outcomes of patients with prostate carcinoma?
    Wilt TJ
    Cancer; 2000 Mar; 88(6):1277-81. PubMed ID: 10717606
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.
    Ravi P; Karnes RJ; Rangel LJ; Pagliaro LC
    J Urol; 2018 Nov; 200(5):1075-1081. PubMed ID: 29709664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically localised prostate cancer.
    Wilt TJ; Thompson IM
    BMJ; 2006 Nov; 333(7578):1102-6. PubMed ID: 17124221
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer.
    Eulau SM; Tate DJ; Stamey TA; Bagshaw MA; Hancock SL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):735-40. PubMed ID: 9652832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine treatment: expected duration stage by stage.
    Schröder FH
    Prostate Suppl; 2000; 10():26-31. PubMed ID: 11056490
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic therapeutic strategies for prostate cancer.
    Nelson WG
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):619-21. PubMed ID: 16167046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.